Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|January 27, 1997
Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free miceM Harada, K Matsunaga, Y Oguchi, et al.
Japanese Heart Journal|November 6, 2001
Angiographic classification of coronary dissections after plain old balloon angioplasty for prediction of regression at follow-upJ Shigeyama, S Ito, H Kondo, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2M Harada, G Matsuzaki, Y Shinomiya, et al.
Japanese Circulation Journal|September 12, 2000
Beneficial application of quantitative coronary angiography (edge detection algorithm) in analysis of dissected coronary arteries to predict long-term patencyH Kondo, S Ito, J Shigeyama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 1, 1996
Ambulatory blood pressure monitoring in evaluating the prevalence of hypertension in adults in Ohasama, a rural Japanese communityY Imai, I Tsuji, K Nagai, et al.
Anticancer Research|August 1, 2025
Endometrial Cancer Metastatic to the Sigmoid Colon and Pelvic Retroperitoneal Space: A Case ReportJunko Mukohyama, Itaru Saito, Satoshi Mochizuki, et al.
Infection and Immunity|December 17, 2009
Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptideHidetaka Nakagaki, Shinichi Sekine, Yutaka Terao, et al.
Internal Medicine (Tokyo, Japan)|June 8, 2001
Insulinoma with subsequent association of Zollinger-Ellison syndromeN Mizuno, S Naruse, M Kitagawa, et al.
Vaccine|February 3, 2007
Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in miceNorimitsu Tanaka, Satoshi Fukuyama, Tatsuya Fukuiwa, et al.
International Journal of Cancer|March 4, 1997
Local injection of OK432 can augment the TH1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potentialT Okamoto, M Harada, K Tamada, et al.
Pageof 17